A detailed history of Park Square Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Park Square Financial Group, LLC holds 174 shares of ABBV stock, worth $40,716. This represents 0.17% of its overall portfolio holdings.

Number of Shares
174
Previous 1,274 86.34%
Holding current value
$40,716
Previous $236 Million 82.96%
% of portfolio
0.17%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$184.85 - $231.54 $203,335 - $254,694
-1,100 Reduced 86.34%
174 $40.3 Million
Q2 2025

Aug 12, 2025

SELL
$170.16 - $206.27 $340 - $412
-2 Reduced 0.16%
1,274 $236 Million
Q1 2025

Apr 30, 2025

BUY
$169.2 - $216.66 $34,516 - $44,198
204 Added 19.03%
1,276 $267 Million
Q4 2024

Feb 28, 2025

BUY
$164.99 - $203.87 $176,869 - $218,548
1,072 New
1,072 $190 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Park Square Financial Group, LLC Portfolio

Follow Park Square Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Square Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Square Financial Group, LLC with notifications on news.